MSLE – satellos bioscience inc. (US:NASDAQ)
Stock Stats
News
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
Satellos to Participate in Upcoming Investor Conferences
Satellos Bioscience (NASDAQ:MSLE) is now covered by analysts at Weiss Ratings. They set a "sell (d-)" rating on the stock.
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
Form 6-K Satellos Bioscience Inc. For: Feb 24
Form 6-K Satellos Bioscience Inc. For: Feb 19
Form 6-K Satellos Bioscience Inc. For: Feb 18
Form 6-K Satellos Bioscience Inc. For: Feb 17
Form 6-K Satellos Bioscience Inc. For: Feb 10
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.